top of page

Unlocking potency through enhanced solubility & bioavailability

DelAQUA ‘s proprietary platform offers a safe, flexible and PEG-free drug solubilization solution that enables convenient delivery of poorly soluble drugs with
improved bioavailability.

About Us

DelAQUA Pharmaceuticals has the solution to poor aqueous drug solubility and limited bioavailability.

Poor solubility of drug candidates is a problem faced by every small molecule pharmaceutical program regardless of company size and expertise. Drug formulation intervention is needed for these drugs to meet their full therapeutic potential and prevent cancellation of strong development programs.

 

Modern drug delivery solutions hold the key to rescuing these programs and increasing pharmaceutical revenue. Without intervention, patients may not receive the best potential therapy. ​

 

Our team of world-renowned scientists have developed a safe, flexible and
biocompatible drug solubilization platform that enables effective delivery of poorly soluble drugs.

iStock-1253392342.jpg

Technology that is flexible & powerful.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Improves Water Solubility for Medications

DelAQUA’s Polymeric micelles increased for over 80% of the drugs tested with our patented POx drug solubilization and delivery technology.

Outperforms Leading Micelle Technologies

Many of the shortcomings of PEG-based polymeric micelles are addressed with DelAQUA’s POx platform that delivers higher loading with greater safety and flexibility.

Improves Water Solubility for Medications

DelAQUA’s POx micelles can deliver multiple drugs to the site of disease at a target synergistic ratio, where other micelles cannot - a powerful, "Lego-like approach."

A platform with potential to treat many diseases.

Rapid screening of poorly soluble drugs with DelAQUA’s proprietary polymer library can quickly identify POx polymers for solubility enhancement. Formulation optimization and scale up can then provide samples for in vitro and in vivo screening for activity, bioavailability and pharmacokinetics. Click on the images below to view DelAQUA's proprietary polymer impact.

Our Publications

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

iStock-1253392342.jpg

Get In Touch

Call Us

215-534-0399​

Laboratory Address

250 Bell Tower Road, Room 2244

Chapel Hill, NC 27599

bottom of page